August 14, 2025
Source: drugdu
40
According to the website of the People's Government of Hainan Province on August 14th, recently, the General Office of the People's Government of Hainan Province issued the "Several Policy Measures of Hainan Province on Further Supporting the High-Quality Development of the Biomedical Industry". The Policy Measures propose to continuously increase support for the research and development of innovative drugs and medical devices. Continue to implement the provincial biomedical industry research and development voucher policy. For the entire process of product research and development, including preclinical research, clinical trials, and industrialization of new achievements, provide financial rewards ranging from 400,000 to 10 million yuan based on phased achievements.
The Policy Measures propose that enterprises both within and outside the province be encouraged to lawfully merge and restructure pharmaceutical enterprises in Hainan Province, revitalize assets on the spot and grow stronger. A 50% interest subsidy will be provided for bank loans arising from participation in mergers and reorganizations for two consecutive years, with a maximum subsidy of 5 million yuan. Encourage enterprises to undergo international certification. For pharmaceutical and medical device enterprises that obtain international authoritative certification, a one-time reward of 2 million yuan will be given in accordance with regulations.
Continue to support the modern biopharmaceutical industry to grow stronger and larger. Encourage enterprises to participate in the national volume-based procurement. For the winning varieties in the national centralized volume-based procurement of drugs and medical devices, a reward of up to 3 million yuan will be given, which is 3% of the actual sales completed at the winning unit price.
Cultivate and develop emerging industries such as biomanufacturing, medical aesthetics, special medical foods, and digital therapeutics. Carry out research, transformation and application in fields such as new vaccines, antibody drugs, cell and gene therapy products, synthetic biology, Marine biological products, and aerospace medicine, and develop the bio-manufacturing industry. Vigorously promote the development of industries such as medical aesthetics and special medical foods.
Strengthen investment and financing support for innovative pharmaceutical enterprises. By leveraging the provincial government guidance funds of Hainan, a number of industrial sub-funds in the field of medicine and health will be established, and the establishment of a biomedicine innovation and transformation fund will be explored to strengthen strategic investment in potential enterprises and high-quality R&D pipelines. Give full play to the role of the provincial-level financing guarantee risk compensation fund pool in Hainan to support the development of pharmaceutical enterprises. Strengthen the "full-chain" services for pharmaceutical enterprises in the capital market, improve the provincial reserve resource pool for listed companies, and continuously promote the listing of pharmaceutical enterprises on domestic and overseas capital markets. Encourage cities, counties and industrial parks to build a multi-level financing support system, promote "park guarantee loans", explore a "invest first, then equity" fund pool for the transformation of scientific and technological achievements, set up funds to assist enterprises and alleviate their difficulties, etc. The provincial finance (provincial government guidance funds) will provide matching support as the situation requires. Encourage pharmaceutical enterprises to carry out future income rights pledge financing, supply chain financing, accounts receivable pledge financing, order financing, factoring financing, etc.
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.